RHEACELL announces "First Patient In": EB-Haus in Salzburg,

RHEACELL announces "First Patient In": EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected

Related Keywords

Israel , Austria , Salzburg , United Kingdom , Chile , Heidelberg , Baden Wüberg , Germany , Argentina , United States , Great Britain , German , Christoph Ganss , Vander Beken , Neuenheimer Feld , Gmbh Co , European Medicines Agency , Intractable Rare Diseases Research , Health News , Therapies Committee , Paul Ehrlich Institute , Cancer Research , German Federal Institute For Vaccines , Proceedings Of The National Academy Sciences , Therapy Medicinal Products , Advanced Therapies Committee , Epidermolysis Bullosa , Rare Diseases Research , Reviews Disease Primers , Investigational Dermatology , Injury Driven Stiffening , Dermis Expedites Skin Carcinoma , National Academy , Chronic Iron Overload Wounds , German Federal Institute ,